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Abstract
Background: Estimates of an individual’s cumulative ultraviolet (UV) radiation exposure can be useful since
ultraviolet radiation exposure increases skin cancer risk, but a comprehensive tool that is practical for use in the
clinic does not currently exist.
The objective of this study is to develop a geographically-adjusted tool to systematically estimate an individual’s
self-reported cumulative UV radiation exposure, investigate the association of these estimates with skin cancer
diagnosis, and assess test reliability.
Methods: A 12-item online questionnaire from validated survey items for UV exposure and skin cancer was
administered to online volunteers across the United States and results cross-referenced with UV radiation indices.
Cumulative UV exposure scores (CUES) were calculated and correlated with personal history of skin cancer in a
case–control design. Reliability was assessed in a separate convenience sample.
Results: 1,118 responses were included in the overall sample; the mean age of respondents was 46 (standard
deviation 15, range 18 – 81) and 150 (13 %) reported a history of skin cancer. In bivariate analysis of 1:2 age-
matched cases (n = 149) and controls (n = 298), skin cancer cases were associated with (1) greater CUES prior to first
skin cancer diagnosis than controls without skin cancer history (242,074 vs. 205,379, p = 0.003) and (2) less
engagement in UV protective behaviors (p < 0.01). In a multivariate analysis of age-matched data, individuals with
CUES in the lowest quartile were less likely to develop skin cancer compared to those in the highest quartile. In
reliability testing among 19 volunteers, the 2-week intra-class correlation coefficient for CUES was 0.94. We have
provided the programming code for this tool as well as the tool itself via open access.
Conclusions: CUES is a useable and comprehensive tool to better estimate lifetime ultraviolet exposure, so that
individuals with higher levels of exposure may be identified for counseling on photo-protective measures.
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Background
Ultraviolet (UV) radiation exposure increases risk for
cutaneous cancers and photo-aging, [1–7] however, sys-
tematic estimation of whether an individual has higher-
than-average sun exposure is difficult in the clinical
setting. UV radiation is an environmental carcinogen,
much like cigarette smoke is an environmental carcino-
gen whose exposure can be estimated using lifetime cu-
mulative “pack-years” in the clinical setting [8]. The
objective of this study was to create a tool that systemat-
ically estimates cumulative UV exposures, and accounts
for geographic locale.
Calculating an individual’s lifetime UV radiation ex-
posure can be challenging [9] in the clinical setting, as it
requires information on (1) the frequency and duration
of UV exposures which can vary over a person’s lifetime,
and (2) the residential history, since UV index varies by
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geographic location. In the research setting, data on (1)
has been gathered through face-to-face [3, 5, 6, 10–15]
or telephone interviews, [16, 17] which can take 45 min
just to collect sun exposure-related variables, [13] and is
too time-consuming for a fast paced dermatology clinic.
Individual diary formats and dosimetry are suitable for
collecting data for short periods of time, but not feasible
for recording lifetime exposures [18–21] over decades.
Finally, though shorter instruments exist, such as the
Sun Exposure Behavior Inventory, [22] these question-
naires do not collect an complete residential and expos-
ure history to allow for assessment of lifetime ultraviolet
exposure.
With regard to data collection and analysis, an
accurate, clinically-useful tool should rapidly parse resi-
dential histories, including the durations of residence,
and link them to UV indices, as all these factors can vary
significantly across a lifetime [20, 22, 23]. Individuals liv-
ing in the United States frequently change their geo-
graphic region of residence over their lifetimes, with
over one-third of the population residing in a state dif-
ferent than the one they were born in [24, 25]. There-
fore, accounting for regional differences in UV index
when estimating an individual’s lifetime UV radiation
exposure is critical. Indeed, the average annual UV index
varies widely within the United States, from 1.9 in An-
chorage, Alaska, to 3.3 in Seattle, Washington to 9.3 in
Honolulu, Hawaii and must be accounted for when
assessing cumulative exposure (Additional file 1: Table
S1).
In this three-part study, we developed an internet-
based, self-administered questionnaire for (1) estimating
cumulative UV exposure (which we term the cumulative
UV exposure score or CUES) and (2) assessed for associ-
ations with sun protective behaviors and skin cancer to
establish a connection with clinically relevant endpoints,
and (3) since sun protective behaviors are known to
change after skin cancer diagnosis, [19, 26–28] we retro-
spectively assessed the CUES before and after first skin
cancer diagnosis to examine whether CUES could detect
a significant difference, as would be expected from data
in the medical literature.
Methods
Recruitment of participants
Following approval by the Stanford University Institu-
tional Review Board (Protocol #29695), volunteers for
this case–control study were recruited online between
March and November 2014 to ensure geographic diver-
sity in residence and travel throughout the United States.
Volunteers were contacted using ResearchMatch, a na-
tional health volunteer registry created by several aca-
demic institutions and supported by the United States
National Institutes of Health as part of the Clinical
Translational Science Award (CTSA) program.
ResearchMatch curates a database of volunteers who
have consented to be contacted by researchers about
health-related studies for which they may be eligible.
Individuals aged 18 years or older who have not re-
sided outside of the United States for more than one
year in their lifetime were eligible for the study. Those
residing outside the United States for greater than one
year were excluded, as UV index data from countries
outside the United States were not always directly com-
parable due to differences in measurement methodology.
All eligible subjects within the 50 states were sent an
email with an invitation to complete the study question-
naire. The random selection feature was utilized in the
recruitment process.
ResearchMatch did not allow us to confirm whether
recruitment emails were received, opened, or read by
recipients, precluding calculation of a traditional
response rate. In addition, we were unable to access the
demographics of individuals who did not participate in
the study to probe for potential bias of responders ver-
sus non-responders. Subjects were not compensated for
their participation in this study.
Study cases were defined as those with a personal his-
tory of skin cancer diagnosed after age 18, and controls
were defined as those without a personal history of skin
cancer. Because initial testing indicated that CUES is
strongly correlated with age, cases and controls were
matched on age. Specifically, age at first skin cancer
diagnosis among cases was matched with age at time of
survey administration among controls. For each case,
two age-matched controls were randomly selected from
the study cohort using standard propensity score
matching.
To test the reliability of the questionnaire responses, a
convenience sample of 19 individuals who were 18 years
and older from the Stanford academic community, and
separate from ResearchMatch participants, was asked to
complete the questionnaire twice with an intervening
two-week period between administrations, with results
compared between the two time points. The sample size
of 19 and the two-week time separation were deter-
mined after literature review of other questionnaire reli-
ability studies. Since there are no published reports of
minimum time interval and sample size requirements
specifically related to ultraviolet radiation exposure sur-
veys, we utilized test-retest time interval and sample size
reported in similar types of studies consisting of self-
reported data outside of dermatology. The two-week
time interval between test and retest for reliability
studies is a generally accepted time frame referenced in
multiple clinical studies [29–32]. For sample size
determination for test-retest reliability studies, a well-
designed study by Hobart and colleagues [33] have
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reported similar intra-class correlation coefficients
across a sample size of 20 versus 120 in a study of self-
reported patient symptoms.
Questionnaire development and administration
Following a PubMed search and review of validated sun-
exposure and skin cancer questionnaire items, a survey
was created consisting of 17 total items. Out of the 17
questions, the first eleven items were used to ascertain
clinically relevant phenomena such as history of skin
cancer or sun protective behaviors for the purposes of
this study.
In actual non-study use, we envision that only items
under the heading “Estimated outdoor exposure time”
and “Estimated location data” would need to be an-
swered to calculate CUES (although the first eleven
items could be clinically useful for the health care pro-
vider, they are not needed to calculate CUES). Skip pat-
terns were automatically implemented and the actual
number of questions answered could be as few as 10, de-
pending on the responses entered. The questionnaire
was administered using a dynamic website interface (see
screenshots included in the Additional file 2 and live
online demo at http://gefeizhu.github.io/cues-study/).
Demographic information collected from respondents
was limited to age and self-reported Fitzpatrick skin
type, based on questions on propensity for tanning and
burning [34, 35]. Next, respondents were asked about
whether there was a personal or family history of skin
cancer, and if so, what type of cancer (possible choices
were “basal cell carcinoma,” “squamous cell carcinoma,”
“melanoma,” “other,” or “don’t know”). Respondents with
a personal history of skin cancer were asked about age
and type of skin cancer at first diagnosis. All respon-
dents answered questions on lifetime frequency of (1)
tanning bed use (possible choices were “0,” “1 – 5,” “6 –
10,” “11 – 100, “and “greater than 100”), (2) blistering
sunburns (possible choices were “0,” “1 – 5,” “6 – 10,”
and “greater than 10”), (3) use of sunscreen, (4) use of
long-sleeved shirts, (5) use of a hat, and (6) shade-
seeking behaviors (possible choices for items 3 – 6 were
“never,” “rarely,” sometimes,” “often,” and “always”);
some of these items were adapted from previously vali-
dated instruments [16, 22] and modified for use in our
questionnaire. For individuals with a personal history of
skin cancer, the 6 items mentioned above appeared twice
to capture behaviors both before and after the date of
diagnosis of their first skin cancer. To minimize recall
bias, identical before and after question pairs related to
sun protective behaviors and skin blistering were sepa-
rated by four questions not related to the question pairs.
Respondents were asked about duration of sun expos-
ure during peak sunlight hours (10 am – 4 pm) during
weekdays and weekends, expressed in hours per day. To
facilitate recall, exposure duration data were collected
for discrete age ranges (0 – 13, 13 – 20, 20 – 40, 40 –
65, 65 – 80, and 80+) that roughly correspond with life
milestones.[10, 31, 36] To account for geographic differ-
ences in UV exposure across the lifetime, respondents
were queried on location of residence and the ages dur-
ing which they lived in each location. The questionnaire
was programmed to require a full and complete lifetime
residential history before respondents were allowed to
submit the responses.
The final item of the online survey tool solicited sub-
jective feedback from respondents in narrative form.
Integration of data validation tools into our online
questionnaire allowed for real-time delivery of feedback
to respondents, minimized unanalyzable and missing
data (99.8 % of all responses were included for analysis,
see Results section) and ensured proper implementation
of inclusion and exclusion criteria.
Calculation of Cumulative UV Exposure Score (CUES)
CUES was calculated from data taken in the sections of
the questionnaire entitled “Estimated outdoor exposure
time” and “Estimated location data”. The most recent
data available from the National Oceanic and Atmos-
pheric Administration (2009–2012) at the time of ques-
tionnaire development was used to calculate average
annual UV indices for 58 anchor cities across the United
States (Additional file 1: Table S1). During this period,
the lowest UV index was 1.9 (Anchorage, AK) and the
highest UV index was 10.3 (San Juan, PR). The UV
index is a standardized, linear measure of erythemally-
weighted irradiance which can theoretically fall between
0 (at night) and 43 [37] but annual UV indices in the
United States generally fall between 1 and 11, with each
unit equal to 0.025 W/m2 [38]. CUES was calculated ac-
cording to CUES = Σ (Hours of Exposure × UV Index).
CUES, which has formal units of W*h/m2, is directly
proportional to standard radiant exposure units (J/m2).
As the CUES is an estimate only, and not data from dos-
imetry, we omit the actual units in the report of the
CUES. Rather the CUES can be viewed as a relative
measure, akin to the pack-year.
The participant’s lifetime was divided into one-year in-
tervals, each of which was assigned a duration of expos-
ure and a location of exposure based on questionnaire
responses. Next, the location of exposure (in “City,
State” format) was resolved into longitude and latitude
coordinates using the publically-available Google Maps
application program interface (API) and the closest an-
chor city was determined using the Haversine formula
for great-circle distances. For each one-year interval, the
hours of exposure was multiplied by the UV index for
the nearest anchor city to obtain an annual UV dose es-
timate. This method was repeated for each one-year
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interval and the annual doses were summed to obtain a
CUES. To minimize human error during this process,
data acquisition, validation and CUES calculation was
completely automated using an open source JavaScript
program developed by the authors. We have provided
the ~1,700 lines of code used to collect questionnaire
data and calculate CUES as an open access resource at
https://github.com/gefeizhu/cues-study so that future
UV indices can be substituted, should they change
significantly.
Association of CUES with clinically relevant endpoints
We compared the CUES of individuals with skin cancer
history prior to their first skin cancer diagnosis with the
CUES of individuals without skin cancer history, in age-
matched fashion. This enabled us to assess whether
CUES could detect differences in lifetime ultraviolet
exposures between those with and without skin cancer,
recapitulating a well-known association in the medical
literature [5, 6, 39].
Second, since sun protective behaviors and UV expo-
sures have been reported in the literature to change after
skin cancer diagnosis, [28, 40, 41] we assessed the ability
of our instrument to detect differences in CUES among
cases before and after first skin cancer diagnosis, as well
as changes in tanning and sun protective behaviors be-
fore and after first skin cancer diagnosis.
Statistical analysis
Student’s t-tests or chi-square tests were used in bivari-
ate analyses on most continuous and categorical vari-
ables, respectively, for comparisons between individuals
with a personal history of skin cancer and those without.
Because age and CUES were not normally distributed,
Wilcoxon’s rank-sum tests were used as nonparametric
alternatives to t-tests in these comparisons. Individuals
could report one or more types of family history of skin
cancer, and therefore two-sample Student’s t-tests were
used to compare these variables.
Each case was matched with 2 controls on age using
standard propensity score matching. One case was ex-
cluded because the respondent had a first diagnosis of
skin cancer before age 18. To estimate the odds of devel-
oping skin cancer, conditional logistic regression was
applied in univariate and multivariate analyses. Interac-
tions and multi-collinearity were assessed in determining
the final multivariate model. Wilcoxon’s signed-rank test
was used to compare CUES and Bowker’s test was used
to compare sun protective behaviors, tanning bed use,
and lifetime history of blistering sunburns before and
after diagnosis of skin cancer among cases.
Test-retest reliability was assessed by calculating an
intraclass correlation coefficient (ICC) for the CUES
score and weighted kappa coefficients for categorical
survey items. In general, kappa scores of 0.75 or greater
reflect excellent agreement, scores of 0.40 to 0.75 reflect
fair-to-good agreement, and scores below 0.4 reflect
poor agreement [42]. The raw and standardized Cron-
bach’s alpha for the questionnaire items was 0.59.
In light of the Cronbach’s alpha score, factor analysis
was performed on use of hat, use of long-sleeved cloth-
ing, shade-seeking behavior, use of sunscreen, Fitzpatrick
skin type, lifetime history of blistering sunburns, and use
of tanning beds to assess dimensionality. After applying
eigenvalue selection criteria, one factor was retained,
comprising: use of hat, use of long-sleeved clothing,
shade-seeking behavior, use of sunscreen, Fitzpatrick
skin type, lifetime number of blistering sunburns, and
use of tanning beds.
All statistical analyses were conducted using SAS (Ver-
sion 9.4, SAS Institute, Inc., Cary, North Carolina).
Results
ResearchMatch sent emails to 60,480 individuals for
this study. 1,120 (1.9 %) completed the study ques-
tionnaire, of which 1,118 (99.8 %) were completely
filled out and met inclusion criteria by age and resi-
dential history.
This group was analyzed for the study and individ-
uals residing in 47 states (see Additional file 3: Figure
S1 for distribution of states). Both of the excluded
questionnaires reported location(s) of residence out-
side of the United States for ≥1 year. A standard re-
sponse rate could not be calculated from the online
format, as there was no way to ascertain that the
email had been read by the potential respondents in
their inboxes.
The mean age of all study participants was 46 years
(range 18 – 81), and 150 (13 %) individuals reported a
personal history of skin cancer. Approximately 70 % of
individuals participating in this study self-reported Fitz-
patrick skin type 2–3, with 20 % self-reporting Fitzpa-
trick skin type 4–6. Other demographic information is
presented in Table 1. The annual UV indices in the re-
ported locales of study participants in the United States
ranged from 1.88 to 10.29. (Additional file 1: Table S1).
In bivariate analyses, individuals with a personal his-
tory of skin cancer were significantly older than those
without a personal history of skin cancer (mean age 61.6
vs. 45.4, p < 0.0001), were more likely to have a family
history of skin cancer (55 % vs. 30 %, p < 0.0001), and
more likely to have Fitzpatrick skin types I or II (59 %
vs. 43 %, p = 0.001).
To further characterize the relationship between devel-
opment of skin cancer and clinical and UV exposure-
related behavioral variables, factor analysis was per-
formed on the questionnaire items. One factor was iden-
tified, with standardized scoring coefficients presented in
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Additional file 4: Table S2. Median factor scores of indi-
viduals with a personal history of skin cancer were sig-
nificantly lower than those without (median −0.2 vs. 0.2,
p < 0.0001), suggesting an inverse relationship between
factor scores and skin cancer risk (Table 1).
Association of CUES with personal history of skin cancer
The median CUES of individuals with a personal history
of skin cancer was significantly higher than those with-
out personal history of skin cancer (241,873 vs. 180,708,
p = 0.0001), as was the total hours of exposure (55,172
Table 1 Characteristics for all participants by personal history of skin cancer, N = 1,118
Parameter Negative personal history of skin cancer Positive personal history of skin cancer p
(n = 968) (n = 150)
Age, mean (SD), in years 45.4 (14.6) 61.6 (11.6) <0.0001
Family history of skin cancer, n (%) 286 (30) 82 (55) <0.0001
Type of family history of skin cancer, n (%)c
Basal cell carcinoma 123 (43) 66 (80) <0.0001
Squamous cell carcinoma 58 (20) 31 (38) 0.0012
Melanoma 73 (26) 19 (23) 0.6528
Other 1 (0.4) 1 (1.2) 0.3464
Don’t know 80 (28) 7 (8) 0.0002
Skin type (Fitzpatrick), n (%) 0.001
1 71 (7) 9 (6)
2 350 (36) 80 (53)
3 315 (33) 35 (23)
4 + 5 + 6 232 (24) 26 (17)
Tanning bed use by number of visits,a n (%) 0.1017
0 537 (55) 100 (67)
1–5 157 (16) 18 (12)
6–10 85 (9) 11 (7)
11–100 152 (16) 19 (13)
>100 37 (4) 2 (1)
Lifetime number of blistering sunburns, n (%) <0.0001
0 165 (17) 14 (9)
1–5 524 (54) 72 (48)
6–10 162 (17) 25 (17)
>10 117 (12) 39 (26)
Age at first skin cancer diagnosis, mean (SD), in years NA 51.4 (13.8) NA
Type of first skin cancer diagnosis, n (%)
Basal cell carcinoma NA 93 (62) NA
Squamous cell carcinoma 20 (13)
Melanoma 17 (11)
Other 7 (5)
Don’t know 13 (9)
Factor score, median (range)d 0.2 (−2.0 – 2.2) −0.2 (−2.3 – 1.4) <0.0001
Lifetime total hours of exposure, median (range) 37,128 (2,496 – 156,520) 55,172 (14,976 – 157,248) <0.0001
CUESb, median (range) 180,708 (11,288 – 778,332) 241,873 (44,858 – 898,344) <0.0001
aTotal number of tanning bed visits per lifetime (negative personal history of skin cancer) or total number of tanning bed visits up until first skin cancer diagnosis
(positive personal history of skin cancer)
bTotal CUES (negative personal history of skin cancer) or CUES prior to first skin cancer diagnosis (positive personal history of skin cancer)
cIndividuals could report a family history of more than one type of cancer, therefore chi-squared testing was not possible
dA single factor was identified during factor analysis, which incorporated Fitzpatrick skin type, use of tanning bed, lifetime number of blistering sunburns, use of
hat, use of long-sleeved clothing, shade-seeking behavior, and use of sunscreen
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vs. 37,128, p < 0.0001). The CUES distributions of indi-
viduals with and without a personal history of skin can-
cer overlapped significantly, as expected for a disease
process with a multifactorial etiology (Table 1).
To assess if CUES is associated with development
of skin cancer, a case–control format was utilized. In
this part of the study, 149 cases (individuals with a
personal history of skin cancer) were matched to 298
controls (individuals with no personal history of skin
cancer), with exclusion of only one individual who re-
ported a history of skin cancer prior to age 18 years.
CUES at time of first skin cancer diagnosis (for those
with a personal history of skin cancer) and total
CUES (for those without) were divided into quartiles
and used as the predictor of interest. In age-matched
case–control analyses, individuals in the lowest quar-
tile of CUES were less likely to report a positive
history of skin cancer compared to those in the high-
est quartile (OR 0.4, 95 % CI 0.2 – 0.7). Cases had
significantly greater CUES prior to first skin cancer
diagnosis compared to total CUES of controls in
matched analyses (242,074 vs. 205,379, p = 0.003)
(Table 2).
A multivariate model using conditional logistic regres-
sion showed that CUES was an independent risk factor
for development of skin cancer, while controlling for
family history of skin cancer and the factor score, which
included Fitzpatrick skin type and several ultraviolet
exposure-related variables (Additional file 4: Table S2).
Individuals with CUES in the 1st quartile (adjusted odds
ratio [AOR] 0.5, 95 % CI 0.2 – 0.97) were less likely to
develop skin cancer compared to those in the highest
quartile independent of covariates (Table 2).
Association of sun protective behaviors with personal
history of skin cancer
In univariate analyses, cases were more likely to report
“rarely” using hats (OR 1.9, 95 % CI 1.1 – 3.2) compared
to controls. Cases were less likely to report “often” seek-
ing shade (OR 0.3, 95 % CI 0.2 – 0.6), “often” (OR 0.3,
95 % CI 0.1 – 0.6) or “always” (OR 0.2, 95 % CI 0.1 –
0.6) using long-sleeved clothing, and “often” (OR 0.3,
95 % CI 0.2 – 0.8) or “always” (OR 0.03, 95 % CI 0.003 –
0.23) using sunscreen. Positive history of tanning bed
use was not significantly different between cases and
controls (Table 2).
In multivariate analysis using conditional logic regres-
sion, Fitzpatrick skin type and many UV exposure-
related variables were collapsed into a single factor
score. Cases reported a significantly lower factor score
compared to controls (AOR 0.5, 95 % CI 0.4 – 0.7), con-
sistent with the UV exposure-related risk factors
included in the calculation of this factor (Table 2 and
Additional file 4: Table S2).
After a skin cancer diagnosis, individuals with a per-
sonal history of skin cancer reported significantly in-
creased engagement in sun-protective behaviors,
including tanning bed avoidance (p = 0.0005), use of sun-
screen (p < 0.0001), use of long-sleeved clothing (p <
0.0001), use of hat (p < 0.0001), shade seeking behavior
(p < 0.0001), and reduced number of blistering sunburns
(p < 0.0001). Additionally, there was a concordant
decrease in the median annual CUES calculated after
skin cancer diagnosis compared to before (4,970 vs.
3,087, p < 0.0001) (Table 3).
To promote the ease of use of the CUES score, a sum-
mary of scores (rounded to the nearest thousand units)
relative to study participants is provided in Table 4, so
that individuals can see whether their scores are above
the median of study participants across the United
States.
Reliability of CUES
To assess the reliability of CUES, a convenience sample
of 19 individuals was recruited outside of Research-
Match from the Stanford academic community and
asked to fill out identical questionnaires before and after
a 2 week period to assess the reliability of survey items.
The weighted kappa/ICC for CUES was 0.94, (95 % CI,
0.86 – 0.98) indicating excellent reliability. Weighted
kappa scores for other questionnaire items ranged from
0.43 (95 % CI 0.23 – 1.00) for shade seeking behavior to
1.00 (95 % CI 1.00 – 1.00) for family history of skin
cancer (Table 5). While the weighted kappa for CUES is
good, the small sample size from the Stanford academic
community could limit its generalizability to the national
survey population.
Feedback from respondents indicated the question-
naire and its online implementation was easy to under-
stand, logical, and brief. All the respondents took less
than 10 min to complete the survey.
Discussion
We report an open-source questionnaire-based
method of calculating cumulative UV radiation expos-
ure that can be used to identify individuals with
higher lifetime UV radiation exposures (e.g. >240,000
units, the median CUES of those with a history of
skin cancer) and accounts for the variety of geo-
graphic differences across the United States. Increased
CUES was associated with a positive personal history
of skin cancer in the overall sample (n = 1,118)
(Table 1) as well as the age-matched case–control
subset analysis (n = 447) in univariate and multivariate
analyses (Table 2). We also report a decrease in
annual CUES and a concordant increase in sun pro-
tective habits following skin cancer diagnosis,(Table 3),
thereby demonstrating the ability of CUES to detect
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Table 2 Sun-Protective behaviors and CUES among skin cancer cases and age-matched controls, N = 447
Parameter Controls (n = 298) Cases (n = 149) Unadjusted Odds Ratio
(95 % confidence interval)a
Adjusted Odds Ratio
(95 % confidence interval)b,c
Fitzpatrick Skin Type, n (%)
1 25 (8) 8 (5) Ref Incorporated into factor
scoree
2 112 (38) 80 (54) 2.26 (0.97 – 5.26)
3 102 (34) 35 (23) 1.10 (0.46 – 2.63)
4 + 5 + 6 59 (20) 26 (17) 1.40 (0.58 – 3.41)
Use of tanning bed, n (%)
0 177 (59) 99 (66) Ref Incorporated into factor
scoree
1–5 42 (14) 18 (12) 0.76 (0.41 – 1.42)
6–10 29 (10) 11 (7) 0.66 (0.30 – 1.42)
11–100 43 (14) 19 (13) 0.77 (0.42 – 1.42)
>100 7 (2) 2 (1) 0.54 (0.11 – 2.59)
Lifetime number of blistering sunburns, n (%)
0 41 (14) 14 (9) Ref Incorporated into factor
scoree
1 –5 156 (52) 72 (48) 1.3 (0.7 – 2.6)
- 10 58 (19) 24 (16) 1.2 (0.5 – 2.6)
>10 43 (14) 39 (26) 2.6 (1.2 – 5.5)
Use of hat, n (%)
Never 78 (26) 32 (21) Ref Incorporated into factor
scoree
Rarely 77 (26) 63 (42) 1.89 (1.11 – 3.23)
Sometimes 80 (27) 25 (17) 0.74 (0.39 – 1.41)
Often 45 (15) 23 (15) 1.20 (0.62 – 2.32)
Always 18 (6) 6 (4) 0.79 (0.28 – 2.21)
Use of long-sleeved clothing, n (%)
Never 13 (4) 19 (13) Ref Incorporated into factor
scoree
Rarely 34 (11) 31 (21) 0.70 (0.29 – 1.66)
Sometimes 58 (19) 39 (26) 0.56 (0.25 – 1.26)
Often 112 (38) 37 (25) 0.29 (0.14 – 0.63)
Always 81 (27) 23 (15) 0.24 (0.11 – 0.55)
Shade seeking, n (%)
Never 25 (8) 25 (17) Ref Incorporated into factor
scoree
Rarely 68 (23) 50 (34) 0.80 (0.42 – 1.54)
Sometimes 120 (40) 52 (35) 0.50 (0.27 – 0.93)
Often 79 (27) 21 (14) 0.31 (0.16 – 0.63)
Always 6 (2) 1 (1) 0.18 (0.02 – 1.76)
Use of sunscreen, n (%)
Never 16 (5) 13 (9) Ref Incorporated into factor
scoree
Rarely 55 (18) 44 (30) 1.01 (0.44 – 2.34)
Sometimes 84 (28) 62 (41) 0.90 (0.41 – 1.97)
Often 97 (33) 29 (19) 0.34 (0.15 – 0.82)
Always 46 (15) 1 (1) 0.03 (0.003 – 0.23)
Factor score, median (range)e 0.2 (−2.0 – 2.2) −0.2 (−2.3 – 1.4) 0.56 (0.43 – 0.72) 0.54 (0.41 –0.71)
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changes in sun exposure after skin cancer diagnoses
that is well known from previous studies [19, 26–28].
Current methods in the clinic to estimate an
individual’s UV exposure are often uni-dimensional
(such as “how many blistering sunburns have you had in
your lifetime?”) or subjective (such as “do you spend a
lot of time outdoors?”), and CUES enables systematic es-
timation that can be performed in the clinic waiting
room such as with a patient’s own smartphone or tablet
by logging onto the publically available website. CUES
can then be incorporated as part of the discussion with
dermatologists on whether more aggressive sun-
protective measures may be beneficial. Of course, skin
cancer risk is multifactorial, and includes factors other
than cumulative UV exposure such as patient’s co-
morbid medical conditions, family history, or Fitzpatrick
skin type. Moreover, CUES does not contribute informa-
tion about the intermittency of exposure events, which
has been positively correlated with an increased risk of
developing melanoma [43]. This tool does not replace
clinical judgment to assess individual risk for skin
cancer.
Nevertheless, a potential use of the CUES may be to
motivate at-risk patients to reduce ongoing UV exposure
through immediate, personalized feedback in clinic or
through other means of conveying such information (e.g.
secure email or messaging systems). The ability of im-
mediate feedback to alter sun protective behaviors has
been shown, for instance through a mobile phone appli-
cation that delivered real-time, location-based UV index
data and encouraged sun protection [44]. Whether re-
ceipt of a CUES upon completion of the survey tool im-
proves sun protective behaviors is the subject of a
forthcoming study.
Several important simplifying assumptions were made
in designing this study. First, since average annual UV
indices were used, we did not account for important di-
urnal, seasonal or yearly differences in the UV index.
Second, we were not able to adjust our CUES using
traditional means, such as applying corrections for body
posture (the UV index is typically measured using do-
simeters installed on a horizontal surface). Finally, we
assumed that self-reported frequencies of exposure
(expressed in hours per week) were constant for epochs
spanning several years. Though future refinements may
enable these assumptions to be diminished or elimi-
nated, a statistically-significant difference in CUES was
detectable between those with more or less sun-
protective behaviors and with skin cancer diagnosis,
even with the aforementioned assumptions.
CUES is not intended to substitute for precise mea-
surements of UV exposure through dosimetry. While
dosimetry is the gold standard method of estimating UV
exposure in short-term research studies, it is not cur-
rently realistic for individuals to carry a dosimeter over
many decades. Dosimetry is also problematic due to pos-
sible heterogeneity in the location the device is worn be-
tween studies and the potential lack of adherence in
wearing the device. We do not claim that CUES is a
physical measure of actual UV exposure by the survey
respondents but is rather an estimate based on self-
reported data. In lieu of testing the content validity of
our measure, we elected to validate CUES by reporting
its ability to detect a well-established association be-
tween UV exposure and sun protective behaviors and
skin cancer.
Moreover, since CUES is not a precise measure of ac-
tual UV dosage, we avoided reporting the formal units
Table 2 Sun-Protective behaviors and CUES among skin cancer cases and age-matched controls, N = 447 (Continued)
Family history of skin cancer,
n (%)
92 (31) 81 (54) 2.63 (1.73 – 3.99) 3.06 (1.92 – 4.88)




CUESd, quartilized, n (%)
4th Quartile 112 (25) 112 (25) Ref Ref
1st Quartile 111 (25) 111 (25) 0.36 (0.19 – 0.69) 0.48 (0.24 – 0.97)
2nd Quartile 112 (25) 112 (25) 0.62 (0.34 – 1.12) 0.76 (0.38 – 1.49)
3rd Quartile 112 (25) 112 (25) 0.63 (0.37 – 1.10) 0.75 (0.41 – 1.37)








cAdjusted for quartilized CUES, family history of skin cancer, and a single factor comprising Fitzpatrick skin type, use of tanning bed, lifetime number of blistering
sunburns, use of hat, use of long-sleeved clothing, shade-seeking, and use of sunscreen
dTotal CUES (controls) or CUES prior to first skin cancer diagnosis (cases)
***p = 0.003 by Wilcoxon rank-sum test
eA single factor was identified during factor analysis, which incorporated Fitzpatrick skin type, use of tanning bed, lifetime number of blistering sunburns, use of
hat, use of long-sleeved clothing, shade-seeking, and use of sunscreen
Zhu et al. BMC Dermatology  (2016) 16:1 Page 8 of 12
of the CUES. Our intention is for CUES to be used to
identify patients at risk for skin cancer in a similar way
as “pack-years” is used to stratify lung cancer risk in
smokers. While CUES does not reflect a physical meas-
urement of UV dose received by an individual, CUES
can be easily incorporated into epidemiological studies
in which lifetime UV exposure is a covariate or inde-
pendent variable of interest. We envision that the CUES
will primarily be of interest to clinicians, as it relies on
self-reported data ascertainable in clinic waiting rooms.
Of course, the CUES is a crude measurement when
compared to studies employing dosimetry, diaries, or
interviews, which allow for precise quantitation of UV
exposure in physical units. However, such methodo-
logical rigor does not add to clinical utility, just as know-
ing the precise number of cigarettes smoked does not
Table 3 Sun-Protective behaviors and CUES before and after skin cancer diagnosis among cases, N = 149
Parameter Before skin cancer After skin cancer Percentage of absolute agreement P
Annual CUES, median (range) units* 4,970 (1,057 – 16,042) 3,087 (0 – 13,353)
Use of tanning bed, n (%)
0 100 (67) 136 (91) 64 % 0.0005
1–5 17 (11) 0 (0)
6–10 11 (7) 5 (3)
11–100 18 (12) 6 (4)
>100 2 (1) 1 (1)
Use of sunscreen, n (%)
Never 13 (9) 2 (1) 29 % <0.0001
Rarely 44 (30) 9 (6)
Sometimes 62 (42) 39 (26)
Often 29 (19) 69 (46)
Always 2 (1) 31 (21)
Use of long-sleeved clothing, n (%)
Never 19 (13) 7 (5) 41 % <0.0001
Rarely 31 (21) 11 (7)
Sometimes 39 (26) 28 (19)
Often 37 (25) 45 (30)
Always 24 (16) 59 (40)
Use of hat, n (%)
Never 32 (21) 10 (7) 29 % <0.0001
Rarely 64 (43) 15 (10)
Sometimes 25 (17) 37 (25)
Often 23 (15) 55 (37)
Always 6 (4) 33 (22)
Shade seeking, n (%)
Never 25 (17) 10 (7) 35 % <0.0001
Rarely 50 (34) 16 (11)
Sometimes 52 (35) 43 (29)
Often 22 (15) 64 (43)
Always 1 (1) 17 (11)
Lifetime number of blistering sunburns, n (%)
0 14 (9) 127 (85) 12 % <0.0001
1 – 5 72 (48) 19 (13)
6 – 10 25 (17) 1 (1)
>10 39 (26) 3 (2)
P-value determined by Bowker’s test
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substantially alter to the management of a smoker who
is known to have a high pack-year history.
There are several important limitations in this
study. First, we were unable to detect increased odds
of developing skin cancer among individuals reporting
tanning bed use, either in the entire sample (Table 1)
or in case–control analyses (Table 2). We stratified
tanning bed use by age, such as aged ≤54 or
>54 years, the median age in our study, but this did
not yield different results (data not shown). The
strong relationship between tanning bed use and UV-
dependent skin cancers, particularly melanoma, is well
established in the literature [45]. Our inability to re-
capitulate these findings in this study is likely a
combination of (1) low sample size, given that only 9
individuals reported using tanning beds >100 times in
their lifetimes, (2) heterogeneity in the dose and spec-
tral characteristics of tanning bed UV radiation, [46]
and (3) our inability to specify the age(s) at which
our respondents used tanning beds, as tanning during
adolescence and young adulthood is more strongly
associated with subsequent skin cancers [45, 47].
A second limitation is potential selection bias, in
that only 1.9 % of individuals contacted by Research-
Match completed the questionnaire. It is possible that
there were important undetected differences between
responders and nonresponders, however, the
ResearchMatch platform did not allow for this type of
assessment.
A third and most important limitation is the possibility
of recall bias, which is inherent in the retrospective and
self-reported nature of this study. This was carefully
considered in the design of the study, and measures
were taken to minimize this bias, namely (A) separating
pairs of identical questions asking about sun protective
behaviors and tanning bed use before and after diagnosis
of skin cancer among those with a positive history and
(B) constraining exposure duration responses to fixed
age epochs (0 – 13, 13 – 20, 20 – 40, 40 – 65, 65 – 80,
and 80+) rather than having the epochs fall before and
after first skin cancer diagnosis. This study would not be
feasible to conduct in prospective fashion due to the
need to follow large numbers of individuals nationally
over many decades with dosimetry data or serial ques-
tionnaire administrations. It is not possible to prospect-
ively “blind” patients to their own diagnosis of skin
cancer, and therefore it would be impossible to remove
this potential recall bias. The retrospective format of
CUES is consistent with how it would be used in the
clinical setting, that is, as a tool that could be used be-
fore or after eliciting the past medical history, itself a
retrospective but necessary part of everyday clinical care
that is also prone to recall bias.
In fact, multiple clinical measures in fields outside
of dermatology in common use rely on patient self-
report, such as the New York Heart Association
(NYHA) functional classification in cardiology or the
Eastern Cooperative Oncology Group (ECOG) per-
formance status score used in oncology. These mea-
sures, like the CUES, are subject to recall bias but
are used ubiquitously in their respective clinical con-
texts due to their utility. Nevertheless, we envision
that recall bias could be explored in future studies,
for example by comparing self-reported data with
Table 5 Test-retest reliability, N = 19
Survey Item Weighted kappa/ICC 95 % Confidence intervals Percentage of absolute agreement
CUES 0.94a 0.86–0.98 NA
Fitzpatrick skin type 0.90 0.79–1.00 72 %
Family history of skin cancer 1.00 1.00–1.00 100 %
Use of sunscreen 0.84 0.71–0.98 72 %
Use of long-sleeved clothing 0.73 0.55–0.91 72 %
Use of hat 0.96 0.88–1.00 94 %
Shade seeking 0.43 0.23–1.00 83 %
History of blistering sunburns 0.87 0.70–1.00 83 %
Residential history 0.99 0.99–1.00 94 %
aIntraclass correlation coefficient (ICC)
Table 4 How your CUES compares to individuals in the study
Your CUESa How Your CUES compares to Individuals in the
study
<205,000 units Below median score for those without
history of skin cancer
205,001–242,000
units
Above median score for those without
history of skin cancer and below the
median score for those with skin cancer
>242,001 units Above median score for those with skin cancer
aThe CUES reported in this table have been rounded to the nearest thousand
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observer-reported data such as those provided by
family members or caregivers, though such data also
carry the risk of bias.
Conclusions
Finally, we make the CUES calculation tool freely avail-
able online in two ways. First, the source code is avail-
able for modification, for instance, should UV indices
change in the future or if customization is needed for
specific populations. Second, the CUES calculator can
be accessed at the link reported in the Methods section
for individual calculation, the result of which can be pro-
vided to a dermatologist or other health care provider by
the patient in their discussion of photo-protective mea-
sures or skin cancer risk.
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